Hsbc Holdings PLC Tiziana Life Sciences LTD Transaction History
Hsbc Holdings PLC
- $159 Billion
- Q1 2025
A detailed history of Hsbc Holdings PLC transactions in Tiziana Life Sciences LTD stock. As of the latest transaction made, Hsbc Holdings PLC holds 105,365 shares of TLSA stock, worth $173,852. This represents 0.0% of its overall portfolio holdings.
Number of Shares
105,365
Previous 105,365
-0.0%
Holding current value
$173,852
Previous $71,000
59.15%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding TLSA
# of Institutions
35Shares Held
3.04MCall Options Held
24KPut Options Held
800-
Dauntless Investment Group, LLC Commerce Township, MI1.74MShares$2.87 Million2.2% of portfolio
-
Jane Street Group, LLC New York, NY168KShares$276,4440.0% of portfolio
-
Omers Administration Corp Toronto, A6145KShares$239,0850.0% of portfolio
-
Morgan Stanley New York, NY139KShares$229,4020.0% of portfolio
-
Zhang Financial LLC96.3KShares$158,8290.01% of portfolio
About Tiziana Life Sciences Ltd
- Ticker TLSA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 102,273,000
- Market Cap $169M
- Description
- Tiziana Life Sciences Ltd, a biotechnology company, focuses on the discovery and development of molecules to treat human diseases in oncology and immunology. The company's lead product candidate in immunology is Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody (mAb) for the treatment of Crohn's, graft versus host, ulcerative colitis, m...